Actual condition survey for the patients with type 2 diabetes mellitus and examination of both predictive and exacerbating factors for nonalcoholic fatty liver disease and arteriosclerotic disease in type 2 diabetes mellitus

Actual condition survey for the patients with type 2 diabetes mellitus and examination of both predictive and exacerbating factors for nonalcoholic fatty liver disease and arteriosclerotic disease in type 2 diabetes mellitus - Examination of actual condition and predictive factor for NAFLD and arteriosclerotic disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041029

Enrollment

4000

Registered

2020-07-10

Start date

2020-07-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease (NAFLD) Nonalcoholic steatohepatitis (NASH) Type 2 diabetes mellitus Cardiovascular disease Arteriosclerotic disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Outpatients from April 1998 to July 2024 who visited the facilities which is related with Ehime University Graduate School of Gastroenterology, Endocrine and Metabolism. 2.Male and female over eighteen years of age 3.Patients who have already been or newly diagnosed with diabetes. 4.Patients, who are in regular visits, agree to participate in this survey by written consent 5.Patients, who have not attended a hospital, do not have no intention of not participating by opt-out.

Exclusion criteria

Exclusion criteria: 1. Patients with pregnancy or lactation 2. Patients judged for inappropriate by doctor

Design outcomes

Primary

Measure	Time frame
1.Examine the relationship between NAFLD and arteriosclerotic disease. 2.Evaluate the correlation between NAFLD related factor and arteriosclerotic change. 3.Compare the risk factor for atherosclerosis between NAFLD and non-NAFLD patients. 4.Explore the factor associated with onset and progress of arteriosclerotic change. 5.Explore the factor associated with onset and progress of NAFLD. 6.Investigate the influence of the NAFLD and arteriosclerotic change on onset of metabolic diseases, cancer, and prognosis.	—

Measure

Time frame

1.Examine the relationship between NAFLD and arteriosclerotic disease. 2.Evaluate the correlation between NAFLD related factor and arteriosclerotic change. 3.Compare the risk factor for atherosclerosis between NAFLD and non-NAFLD patients. 4.Explore the factor associated with onset and progress of arteriosclerotic change. 5.Explore the factor associated with onset and progress of NAFLD. 6.Investigate the influence of the NAFLD and arteriosclerotic change on onset of metabolic diseases, cancer, and prognosis.

—

Secondary

Measure	Time frame
(1) Explore the factors associated with atherosclerotic changes.	—

Countries

Japan

Contacts

Public ContactTeruki Miyake

Ehime University Graduate School of Medicine Department of Gastroenterology and Metabology

teruki-ygc@umin.ac.jp+81899605308

Outcome results